GLP-1 Intestine and Stomach Paralysis Complications A recent case report published in January 2024 discussed Semaglutides (the active ingredient in Ozempic, Wegovy, and Rybelsus) known gastrointestinal adverse effects, and highlighted the need [for medical providers] to recognize medication-induced gastroparesis as a possible diagnosis, especially in individuals with risk factors. The weight loss and diabetes drug lawyers here at Mazie Slater are investigating claims of serious side effects and complications in people who utilized certain glucagon-like peptide 1 (GLP-1) receptor agonist (RA) medications for diabetes and weight loss
"Our growing formulary addresses the reality that weight care is not one-size-fits-all
Furthermore, data on the long-term safety and tolerability of astaxanthin, particularly at higher doses or with prolonged administration, remain limited
NEJM , Malkud, Shashikant
Sweet taste modulation : By interacting with taste receptors on the tongue, it can temporarily reduce the perception of sweetness and decrease the intake of simple sugars
